Beacon Dermatology Inc /ID# 240741

Calgary, Alberta T3A 2N1

0 studies enrolling now · 1 studies all time

What they study most

Hidradenitis Suppurativa

Studies at this site

• A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy — Running, not enrolling